Publications by authors named "Roman Willi"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

75,033

Total Likes

1,796

Extended Reach

513,788

Social Features

122
O
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Stephen L Hauser, Amit Bar-Or, Jeffrey A Cohen, Giancarlo Comi, Jorge Correale, Patricia K Coyle, Anne H Cross, Jerome de Seze, David Leppert, Xavier Montalban

August 2020

Videos about Article: user user

2 1 5 119 4 141

View All Article and Social Media Activity
S
Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial.
Amit Bar-Or, Xavier Montalban, Xixi Hu, Harald Kropshofer, Petra Kukkaro, Roman Willi

Neurol Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years.
Stephen L Hauser, Anne H Cross, Kevin Winthrop, Heinz Wiendl, Jacqueline Nicholas, Roman Willi

Mult Scler· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II.
Jutta Gärtner, Stephen L Hauser, Amit Bar-Or, Xavier Montalban, Jeffrey A Cohen, Roman Willi

Mult Scler· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of ofatumumab versus placebo in relapsing multiple sclerosis patients from Japan and Russia: Phase 2 APOLITOS study.
Jun-Ichi Kira, Jin Nakahara, Denis V Sazonov, Takayoshi Kurosawa, Isao Tsumiyama, Roman Willi

Mult Scler· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study.
Amit Bar-Or, Heinz Wiendl, Xavier Montalban, Enrique Alvarez, Maria Davydovskaya, Roman Willi

Mult Scler· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials.
Tjalf Ziemssen, Douglas L Arnold, Enrique Alvarez, Anne H Cross, Roman Willi

Front Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic-B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis.
Huixin Yu, Gordon Graham, Olivier J David, Joseph M Kahn, Marina Savelieva, Roman Willi

CNS Drugs· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infusion of anti-Nogo-A antibodies in adult rats increases growth and synapse related proteins in the absence of behavioral alterations.
Luis M Craveiro, Oliver Weinmann, Bernd Roschitzki, Roman R Gonzenbach, Björn Zörner, Roman Willi

Exp Neurol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered GSK3β signaling in an infection-based mouse model of developmental neuropsychiatric disease.
Roman Willi, Anja Harmeier, Sandra Giovanoli, Urs Meyer

Neuropharmacology· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nogo and Nogo receptor: relevance to schizophrenia?
Roman Willi, Martin E Schwab

Neurobiol Dis· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice.
Sandra Giovanoli, Harald Engler, Andrea Engler, Juliet Richetto, Mareike Voget, Roman Willi

Science· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutive genetic deletion of the growth regulator Nogo-A induces schizophrenia-related endophenotypes.
Roman Willi, Oliver Weinmann, Christine Winter, Julia Klein, Reinhard Sohr

J Neurosci· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis